CBS vous accompagne

Nos adhérents

Newsletter CBS

Recevez votre lettre d'information

Études de marché

Chaque adhérent du pôle Cancer-Bio-Santé bénéficie d’un accès en ligne gratuit à l’intégralité des études de marché du domaine de la santé de la société « Business Insights ». Ce service, offert par le pôle à ses adhérents, représente un formidable et précieux outil stratégique.
Liste des études disponibles en 2010 :

Therapy Outlook

1. The Cardiovascular Market Outlook to 2015
2. Cancer Market Outlook to 2015
3. The CNS Market Outlook to 2015
4. The Hepatitis Market Outlook to 2015
5. The Global HIV/AIDS & STD Market Outlook to 2015
6. The Lifestyle Disorders Market Outlook to 2014
7. The Global Respiratory Market to 2015
8. The Aesthetic Dermatology Market to 2015
9. The Genitourinary Market (sexual & erectile dysfunction, urinary incontinence) to 2015
10. The Future of the Biologicals Market
11. Innovations in Mental Health & Market Outlook to 2015
12. The Specialty Pharmaceutical Market Outlook

Biotech & R&D

13. Breaking down cancer: Biomarkers, imaging agents, screening and targeted therapeutics
14. Future of Biologics - Creating a stable base for companies
15. Biomarkers in Late Stage Clinical Trials
16. Opportunities in Non-Surgical Bio-Implants
17. Future of the Generics Industry: Deals, Innovation & Challenges
18. Innovations in the Treatment of Neurodegenerative Disorders (Alzheimer's, Multiple Sclerosis, Parkinson’s etc)
19. Innovations in Neurostimulators: Technological Advances and Market Opportunities
20. Generics Launch Strategies in the EU: Impact of IP variations
21. The Biologics Market Opportunity – The Most Promising Products through 2015
22. The Future of Regenerative Medicine
23. OTC Opportunities in Europe, the US and Japan
24. OTC Market in Emerging Countries
25. Innovations and Opportunities in Therapeutic Vaccines
26. Generics Market Outlook in Emerging Markets
27. Trends in Generics Industry Ownership

Top 10 series

28. Top 10 Pharma Companies in Emerging Markets
29. The Top 10 Cardiovascular Device Companies
30. The Top 10 Pharmaceutical Companies in Latin America
31. Top 10 Pharma Companies in China
32. Top 10 Orthopedic Device Companies
33. Top 10 Biotech Companies
34. The Top 10 Eastern European Pharmaceutical Companies

Emerging Markets

35. The Australian Pharmaceutical Market Outlook to 2015
36. The Russian Pharmaceutical Market Outlook to 2014
37. The South Korean Pharmaceutical Market Outlook to 2014
38. The South African Pharmaceutical Market Outlook to 2014

Strategic Planning

39. Pricing & Reimbursement in Emerging Markets - Investigating entry opportunities
40. Opportunities in Emerging Pharma Markets
41. Opportunities in Orphan Drugs
42. Regulatory Requirements & State of IP in Emerging Markets
43. Strategies for Supergenerics
44. The Funding Landscape for Small Biopharma Ventures, 2010-2015
45. The Private Health Insurance Market in Europe
46. P&R - new approaches to gaining market access (e.g. risk-sharing)
47. Impact of US Healthcare Reform on the Future of the Biopharmaceutical Industry
48. Building Biotech Technology Transfer Opportunities
49. Business Intelligence in the Pharmaceutical Market

Drug Discovery

1. Nanotechnology in Healthcare
2. Drug Discovery Collaborations between Academia and the Pharmaceutical Industry
3. Drug Discovery Trends in Emerging Markets (focus on Korea, India, China)
4. Preclinical Models
5. Preclinical Development of Monoclonal Antibodies and Related Biologicals
6. The Future of GPCRs in Drug Discovery
7. Innovations in Combating Infectious Diseases

Pharmaceutical Outsourcing

1. Investigating Clinical Trial Costs
2. The Contract Sales Organization (CSO) Market Outlook to 2015
3. The Future of R&D Outsourcing
4. Strategies for Managing Pharmaceutical Workforce and Site Reductions
5. Top 10 CMOs in China
6. Clinical Trial Recruitment Strategies

Drug Delivery

1. Delivering Opportunities in the Inhalable Drugs Market
2. Innovations in Injectables
3. Innovations in Oral Solid Drug Delivery
4. Transdermal drug delivery
5. Strategic Partnerships in Drug Delivery/Licensing-in Drug Delivery Technologies (include strategic co-marketing)
6. Innovations in Delivering Cancer Therapy

Diagnostic Series

1. The Future of Cardiovascular Diagnostics
2. The Future of Molecular Diagnostics
3. Point of Care Testing
4. Genomics, Proteomics and Metabolomics in Diagnostics
5. Advances in Imaging Biomarkers
6. Pricing and Reimbursement Strategies for Diagnostics
7. Integrated diagnostics - IVD2

Chemicals

1. The Global Active Pharmaceutical Ingredients (API) Market
2. The Top 10 European Specialty Chemicals Companies
3. The Top 10 Global Fine Chemicals Companies
4. The Top 10 US Specialty Chemicals Companies
5. The Global Market Outlook for Agrochemicals to 2015
6. Global Growth Strategies for Chemical Companies
7. Market Outlook for Enzymes in Pharmaceutical Manufacturing
8. Pharmaceutical Fine Chemicals – status and outlook